Cargando…
Prevalence of hepatocarcinoma-related hepatitis B virus mutants in patients in grey zone of treatment
BACKGROUND: Antiviral treatment of patients with chronic hepatitis B (CHB) in the grey zone of treatment comands risk management in order to optimize the health outcome. In this sense, the identification of HBV mutants related with an increased risk of hepatocellular carcinoma (HCC) could be useful...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6801187/ https://www.ncbi.nlm.nih.gov/pubmed/31636479 http://dx.doi.org/10.3748/wjg.v25.i38.5883 |